Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Dephosphorylation of threonine-821 of the retinoblastoma tumor suppressor protein (Rb) is required for apoptosis induced by UV and Cdk inhibition.

Lentine B, Antonucci L, Hunce R, Edwards J, Marallano V, Krucher NA.

Cell Cycle. 2012 Sep 1;11(17):3324-30. doi: 10.4161/cc.21693. Epub 2012 Aug 16.

2.
3.

Evidence that Fas-induced apoptosis leads to S phase arrest.

N'cho M, Brahmi Z.

Hum Immunol. 2001 Apr;62(4):310-9.

PMID:
11295463
4.
5.

Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest.

Strobeck MW, Fribourg AF, Puga A, Knudsen ES.

Oncogene. 2000 Apr 6;19(15):1857-67.

6.

Retinoblastoma protein dephosphorylation induced by D-erythro-sphingosine.

Chao R, Khan W, Hannun YA.

J Biol Chem. 1992 Nov 25;267(33):23459-62.

8.
9.
10.
12.
13.

Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.

Fribourg AF, Knudsen KE, Strobeck MW, Lindhorst CM, Knudsen ES.

Cell Growth Differ. 2000 Jul;11(7):361-72.

14.

Dephosphorylation of Rb (Thr-821) in response to cell stress.

Krucher NA, Rubin E, Tedesco VC, Roberts MH, Sherry TC, De Leon G.

Exp Cell Res. 2006 Sep 10;312(15):2757-63. Epub 2006 May 10.

PMID:
16764854
15.

The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity.

Alessi F, Quarta S, Savio M, Riva F, Rossi L, Stivala LA, Scovassi AI, Meijer L, Prosperi E.

Exp Cell Res. 1998 Nov 25;245(1):8-18.

PMID:
9828096
16.

Docking-dependent regulation of the Rb tumor suppressor protein by Cdk4.

Wallace M, Ball KL.

Mol Cell Biol. 2004 Jun;24(12):5606-19.

17.

Involvement of RB kinases and phosphatases in life and death decisions.

An B, Dineley K, Zhang L, Termin T, Meijer L, Dou Q.

Oncol Rep. 1997 Nov-Dec;4(6):1129-34.

PMID:
21590208
18.

Retinoblastoma tumor suppressor protein signals through inhibition of cyclin-dependent kinase 2 activity to disrupt PCNA function in S phase.

Sever-Chroneos Z, Angus SP, Fribourg AF, Wan H, Todorov I, Knudsen KE, Knudsen ES.

Mol Cell Biol. 2001 Jun;21(12):4032-45.

19.
20.

Supplemental Content

Support Center